Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesAmortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cellebrite DI (CLBT) Non Operating Investment Income: 2022-2024

Historic Non Operating Investment Income for Cellebrite DI (CLBT) over the last 3 years, with Dec 2024 value amounting to $113,000.

  • Cellebrite DI's Non Operating Investment Income fell 76.54% to $198,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $695,000, marking a year-over-year decrease of 14.93%. This contributed to the annual value of $113,000 for FY2024, which is 77.67% down from last year.
  • Per Cellebrite DI's latest filing, its Non Operating Investment Income stood at $113,000 for FY2024, which was down 77.67% from $506,000 recorded in FY2023.
  • Cellebrite DI's 5-year Non Operating Investment Income high stood at $506,000 for FY2023, and its period low was -$502,000 during FY2022.
  • Moreover, its 3-year median value for Non Operating Investment Income was $113,000 (2024), whereas its average is $39,000.
  • Its Non Operating Investment Income has fluctuated over the past 5 years, first skyrocketed by 200.80% in 2023, then slumped by 77.67% in 2024.
  • Over the past 3 years, Cellebrite DI's Non Operating Investment Income (Yearly) stood at -$502,000 in 2022, then spiked by 200.80% to $506,000 in 2023, then tumbled by 77.67% to $113,000 in 2024.